Veronica Salais Michaus, Medical Oncologist at the National Institute of Cancerology in Mexico, shared a post on LinkedIn:
“Discussing the MATTERHORN trial with colleagues from the global oncology community was an incredibly enriching experience. These conversations not only deepen our understanding of emerging evidence but also challenge us to rethink how we approach the treatment of gastrointestinal cancers.
Grateful for the opportunity to exchange ideas, learn from outstanding experts, and contribute to meaningful scientific dialogue. Looking forward to many more discussions that continue pushing our field forward.”
Other articles featuring Veronica Salais Michaus on OncoDaily.
